CorVel Form 144: 900-share option exercise and planned sale disclosed

Rhea-AI Filing Summary

CorVel Corporation (CRVL) insider disclosure shows a proposed sale of 900 common shares through Morgan Stanley Smith Barney on 08/19/2025 with an aggregate market value of $80,251.02. The filer reports acquiring the 900 shares via a stock option exercise on 08/19/2025 and paying in cash. The filing also lists a prior sale of 900 shares by the same person on 05/27/2025 that generated $102,002.58 in gross proceeds. The company has 51,312,748 shares outstanding, so the proposed sale represents a de minimis fraction of total shares. The filer certifies they are not aware of any undisclosed material adverse information about the issuer.

Positive

• Timely, detailed disclosure of the proposed sale, prior sale, acquisition method (option exercise), and cash payment
• Transaction size is immaterial relative to total shares outstanding (900 shares vs 51,312,748 outstanding)

Negative

• None.

Insights

Securities Analyst

TL;DR: Small, routine insider sale and option exercise; immaterial to capitalization but relevant for ownership tracking.

The filing discloses an insider stock option exercise and an associated proposed sale of 900 shares valued at $80,251.02, plus a prior sale of 900 shares that produced $102,002.58. Against 51,312,748 shares outstanding, these transactions are immaterial to the company’s market capitalization and unlikely to affect trading or valuation. The disclosure is standard under Rule 144 and provides transparency on insider liquidity events. No earnings or operational metrics are included to change an investment thesis.

Compliance/Risk Analyst

TL;DR: Disclosure appears complete for Rule 144; signer attests no undisclosed material adverse information.

The form documents acquisition via option exercise and intended resale through a broker, with cash payment noted. The signer’s attestation that they lack undisclosed material adverse information is standard and important for Rule 144 compliance. There are no indications of unusual payment terms, aggregation issues, or nonstandard consideration. From a compliance perspective the filing appears routine and appropriately detailed for the transactions reported.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	900	80251.02	51312748	08/19/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/19/2025	Stock Option Exercise	Issuer			900	08/19/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MARK BERTELS 5128 Apache Plume Road Suite 400 Fort Worth TX 76109	Common	05/27/2025	900	102002.58

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What securities does the Form 144 for CRVL report?

The notice reports a proposed sale of 900 common shares of CorVel Corporation.

How were the 900 shares acquired according to the filing?

The filing states the 900 shares were acquired via a stock option exercise on 08/19/2025 with payment in cash.

What is the aggregate market value of the proposed sale?

The aggregate market value is listed as $80,251.02 for the 900 shares proposed to be sold.

Has the filer sold any CRVL shares recently?

Yes. The filing shows a prior sale of 900 shares on 05/27/2025 with gross proceeds of $102,002.58.

How large is this sale relative to CorVel's outstanding shares?

CorVel has 51,312,748 shares outstanding; the 900-share sale is a de minimis fraction of that total.